SALONPAS Drug Patent Profile

✉ Email this page to a colleague

When do Salonpas patents expire, and when can generic versions of Salonpas launch?

Salonpas is a drug marketed by Hisamitsu Pharm Co and is included in one NDA. There are two patents protecting this drug.

This drug has twenty patent family members in sixteen countries.

The generic ingredient in SALONPAS is menthol; methyl salicylate. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the menthol; methyl salicylate profile page.

DrugPatentWatch^® Generic Entry Outlook for Salonpas

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be January 3, 2030. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

Try a Trial

Summary for SALONPAS

International Patents:	20
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	2
Clinical Trials:	1
Patent Applications:	90
Formulation / Manufacturing:	see details
DailyMed Link:	SALONPAS at DailyMed

Drug patent expirations by year for SALONPAS

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for SALONPAS

Generic Entry Date for SALONPAS^: ⤷ Try a Trial* Constraining patent/regulatory exclusivity: ⤷ Try a Trial NDA: 022029 Dosage: PATCH;TOPICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for SALONPAS

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Scilex Pharmaceuticals, Inc.	Phase 1

See all SALONPAS clinical trials

US Patents and Regulatory Information for SALONPAS

SALONPAS is protected by two US patents.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of SALONPAS is ⤷ Try a Trial.

This potential generic entry date is based on patent ⤷ Try a Trial.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting SALONPAS

Adhesive preparation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hisamitsu Pharm Co	SALONPAS	menthol; methyl salicylate	PATCH;TOPICAL	022029-001	Feb 20, 2008		OTC	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Hisamitsu Pharm Co	SALONPAS	menthol; methyl salicylate	PATCH;TOPICAL	022029-002	Nov 5, 2012		OTC	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Hisamitsu Pharm Co	SALONPAS	menthol; methyl salicylate	PATCH;TOPICAL	022029-001	Feb 20, 2008		OTC	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Hisamitsu Pharm Co	SALONPAS	menthol; methyl salicylate	PATCH;TOPICAL	022029-002	Nov 5, 2012		OTC	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for SALONPAS

When does loss-of-exclusivity occur for SALONPAS?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Australia

Patent: 07279643
Estimated Expiration: ⤷ Try a Trial

Brazil

Patent: 0712396
Estimated Expiration: ⤷ Try a Trial

Canada

Patent: 52220
Estimated Expiration: ⤷ Try a Trial

China

Patent: 1442993
Estimated Expiration: ⤷ Try a Trial

European Patent Office

Patent: 47845
Estimated Expiration: ⤷ Try a Trial

Hungary

Patent: 47985
Estimated Expiration: ⤷ Try a Trial

Japan

Patent: 2008016077
Estimated Expiration: ⤷ Try a Trial

Patent: 30423
Estimated Expiration: ⤷ Try a Trial

Malaysia

Patent: 9142
Estimated Expiration: ⤷ Try a Trial

Mexico

Patent: 08014574
Estimated Expiration: ⤷ Try a Trial

New Zealand

Patent: 2705
Estimated Expiration: ⤷ Try a Trial

Russian Federation

Patent: 41649
Estimated Expiration: ⤷ Try a Trial

Patent: 08144958
Estimated Expiration: ⤷ Try a Trial

Singapore

Patent: 4034
Estimated Expiration: ⤷ Try a Trial

South Korea

Patent: 1420450
Estimated Expiration: ⤷ Try a Trial

Patent: 090035474
Estimated Expiration: ⤷ Try a Trial

Spain

Patent: 55027
Estimated Expiration: ⤷ Try a Trial

Taiwan

Patent: 14299
Estimated Expiration: ⤷ Try a Trial

Patent: 0817013
Estimated Expiration: ⤷ Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering SALONPAS around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Taiwan	I414299		⤷ Try a Trial
Mexico	2008014574	PREPARACION ADHESIVA. (ADHESIVE PREPARATION.)	⤷ Try a Trial
China	101442993	Adhesive preparation	⤷ Try a Trial
Canada	2652220	PREPARATION ADHESIVE (ADHESIVE PREPARATION)	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration